In cancer, hERG1 regulates different aspects of neoplastic progression (i.e. cell proliferation and survival, cell invasiveness and angiogenesis), and behaves as a powerful diagnostic and prognostic marker both in solid cancers [14, 15] and hematologic malignancies [16, 17]. This evidence concerns the gene KCNH2 and cancer.